Drug development
IDEAYA discovers and develops targeted medicines for cancer, then moves the best programs through testing in patients. It focuses on small-molecule drugs and other precision oncology treatments.
Decide at what price you'd be comfortable buying and we'll help you stay ready.
IDEAYA Biosciences is a biotechnology company that develops cancer drugs aimed at tumors with specific genetic weaknesses. Its work focuses on precision oncology, especially small-molecule medicines designed to block the pathways cancer cells depend on while sparing healthier cells. The company’s main assets are its drug candidates and the science behind matching the right drug to the right tumor type.
IDEAYA does not sell consumer products. It makes money mainly through collaboration deals with larger pharmaceutical companies, plus licensing payments, research funding, milestone payments, and potential royalties if partnered drugs succeed. If its own programs reach the market, it could also earn direct drug sales revenue, but today it is primarily a drug developer rather than a commercial seller.
What makes IDEAYA’s business different is its focus on synthetic lethality and other biomarker-driven cancer targets. Instead of trying to treat all cancers the same way, it builds medicines for patients whose tumors carry certain mutations or vulnerabilities. That places the company in the high-risk, high-reward part of biotech, where scientific validation and partner relationships are central to the business model.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
New to Alpha Spread? Create free account
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more